US Patent Issued to ReversPAH on Oct. 14 for "Methods and compositions for treating chronic obstructive pulmonary disease, asthma, pneumonia, bronchitis, cystic fibrosis, pulmonary edema, interstitial lung disease, sarcoidosis, idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and pulmonary arterial hypertension" (Colorado, Illinois Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,488, issued on Oct. 14, was assigned to ReversPAH LLC (Denver).

"Methods and compositions for treating chronic obstructive pulmonary disease, asthma, pneumonia, bronchitis, cystic fibrosis, pulmonary edema, interstitial lung disease, sarcoidosis, idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and pulmonary arterial hypertension" was invented by Norbert F. Voelkel (Denver), Charles Magolske (Denver) and Erik R. Eglite (Lake Forest, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating COPD, Asthma, Pneumonia, Bronchitis, Cystic Fibrosis, Pulmonary Edema, Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmon...